Skip to main navigation Skip to search Skip to main content

Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S104-S105
JournalEuropean Journal of Cancer
Volume174
DOIs
StatePublished - Oct 2022

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this